(S (PP (IN In) (NP (DT this) (NN paper))) (, ,) (NP (PRP we)) (VP (VBP study) (NP (NP (DT a) (NN novel) (NN problem)) (: :) (`` ``) (NP (NP (JJ automatic) (NN prescription) (NN recommendation)) (PP (IN for) (NP (NNP PD) (NNS patients)))))) (. .) ('' ''))
(S (S (VP (TO To) (VP (VB realize) (NP (DT this) (NN goal))))) (, ,) (NP (PRP we)) (ADVP (RB first)) (VP (VB build) (NP (DT a) (NN dataset)) (PP (IN by) (S (VP (VBG collecting) (NP (NP (NP (CD 1) (-RRB- -RRB-) (NP (NNS symptoms))) (PP (IN of) (NP (NNP PD) (NNS patients)))) (, ,) (CC and) (VP (LST (CD 2) (-RRB- -RRB-)) (NP (NP (PRP$ their) (NN prescription) (NN drug)) (VP (VBN provided) (PP (IN by) (NP (NNS neurologists))))))))))) (. .))
(S (ADVP (RB Then)) (, ,) (NP (PRP we)) (VP (VBP build) (NP (DT a) (JJ novel) (JJ computer-aided) (NN prescription) (NN model)) (PP (IN by) (S (VP (VBG learning) (NP (NP (DT the) (NN relation)) (PP (IN between) (NP (NP (VBN observed) (NNS symptoms)) (CC and) (NP (NN prescription) (NN drug))))))))) (. .))
(S (ADVP (RB Finally)) (, ,) (PP (IN for) (NP (DT the) (JJ new) (VBG coming) (NNS patients))) (, ,) (NP (PRP we)) (VP (MD could) (VP (VB recommend) (PRN (-LRB- -LRB-) (S (VP (NN predict))) (-RRB- -RRB-)) (NP (JJ suitable) (NN prescription) (NN drug)) (PP (IN on) (NP (PRP$ their) (VBN observed) (NNS symptoms))) (PP (IN by) (NP (PRP$ our) (NN prescription) (NN model))))) (. .))
(S (PP (IN From) (NP (DT the) (NN methodology) (NN part))) (, ,) (NP (NP (PRP$ our) (VBN proposed) (NN model)) (, ,) (ADVP (RB namely)) (NP (NP (NNP Prescription) (NN viA) (NNP Learning) (NN lAtent) (NNP Symptoms)) (PRN (-LRB- -LRB-) (NP (NNP PALAS)) (-RRB- -RRB-))) (, ,)) (VP (MD could) (VP (VB recommend) (NP (NN prescription)) (S (VP (VBG using) (NP (NP (DT the) (JJ multi-modality) (NN representation)) (PP (IN of) (NP (DT the) (NNS data)))))))) (. .))
(S (PP (IN In) (NP (NNP PALAS))) (, ,) (NP (DT a) (JJ latent) (NN symptom) (NN space)) (VP (VBZ is) (VP (VBN learned) (S (VP (TO to) (ADVP (RBR better)) (VB model) (NP (NP (DT the) (NN relationship)) (PP (IN between) (NP (NP (NNS symptoms)) (CC and) (NP (NN prescription) (NN drug))))))) (, ,) (SBAR (IN as) (S (NP (EX there)) (VP (VBZ is) (NP (NP (DT a) (JJ large) (JJ semantic) (NN gap)) (PP (IN between) (NP (PRP them))))))))) (. .))
(S (ADVP (RB Moreover)) (, ,) (NP (PRP we)) (VP (VBP present) (NP (NP (DT an) (JJ efficient) (VBG alternating) (NN optimization) (NN method)) (PP (IN for) (NP (NNP PALAS))))) (. .))
(S (NP (PRP We)) (VP (VBD evaluated) (NP (PRP$ our) (NN method)) (S (VP (VBG using) (NP (NP (DT the) (NNS data)) (VP (VBN collected) (PP (IN from) (NP (CD 136) (JJ PD) (NNS patients))) (PP (IN at) (NP (NNP Nanjing) (NNP Brain) (NNP Hospital)))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (MD can) (VP (VB be) (VP (VBN regarded) (PP (IN as) (NP (NP (DT a) (JJ large) (NN dataset)) (PP (IN in) (NP (NNP PD) (NN research) (NN community)))))))))))))) (. .))
(S (NP (DT The) (JJ experimental) (NNS results)) (VP (VBP demonstrate) (NP (NP (DT the) (NX (NN effectiveness)) (CC and) (NX (JJ clinical) (NN potential))) (PP (IN of) (NP (PRP$ our) (NN method))) (PP (IN in) (NP (DT this) (NN recommendation) (NN task))) (, ,) (SBAR (IN if) (S (VP (VBN compared) (PP (IN with) (NP (JJ other) (VBG competing) (NNS methods)))))))) (. .))
